Mild Hyperthermia Enhances Transport of Liposomal Gemcitabine and Improves In Vivo Therapeutic Response

Advanced Healthcare Materials

Volumn 4, Issue 7, 2015, Pages 1092-1103

  Kirui, Dickson K ^a   Celia, Christian ^a,b   Molinaro, Roberto ^a,c   Bansal, Shyam S ^a   Cosco, Donato ^c   Fresta, Massimo ^c   Shen, Haifa ^a,d   Ferrari, Mauro ^a,d  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Biological barriers; Cancer nanotherapeutics; Cancer therapy; Liposomal gemcitabine; Mild hyperthermia

Indexed keywords

CONTROLLED DRUG DELIVERY; DISEASES; DRUG PRODUCTS; LIPOSOMES; NANORODS; TARGETED DRUG DELIVERY; TUMORS;

BIOLOGICAL BARRIER; CANCER NANOTHERAPEUTICS; CANCER THERAPY; GEMCITABINE; MILD HYPERTHERMIA;

HYPERTHERMIA THERAPY;

GEMCITABINE; LIPOSOME; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; GOLD; NANOTUBE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL POPULATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ENCAPSULATION; HYPERTHERMIC THERAPY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CANCER; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; THERMOSTABILITY; TRANSITION TEMPERATURE; TUMOR MICROENVIRONMENT; TUMOR VOLUME; ANALOGS AND DERIVATIVES; ANIMAL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; FEVER; MULTIMODALITY CANCER THERAPY; PANCREATIC NEOPLASMS; PATHOPHYSIOLOGY; PROCEDURES; THERMOTHERAPY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DRUG DELIVERY SYSTEMS; FEVER; GOLD; HYPERTHERMIA, INDUCED; LIPOSOMES; MICE; NANOTUBES; PANCREATIC NEOPLASMS;

EID: 84929519770     PISSN: 21922640     EISSN: 21922659     Source Type: Journal    
DOI: 10.1002/adhm.201400738     Document Type: Article

References (53)

1. V. P. Chauhan, R. K. Jain, Nat. Mater. 2013, 12, 958.
2. V. P. Chauhan, T. Stylianopoulos, Y. Boucher, R. K. Jain, Ann. Rev. Chem. Biomol. Eng. 2011, 2, 281.
3. R. K. Jain, J. Clin. Oncol. 2013, 31, 2205.
4. K. Sano, T. Nakajima, P. L. Choyke, H. Kobayashi, ACS Nano 2013, 7, 717.
5. D. Lu, M. G. Wientjes, Z. Lu, J. L. S. Au, J. Pharmacol, Exp. Ther. 2007, 322, 80.
6. V. H. Fingar, J. Clin, Laser Med. Surg. 1996, 14, 323.
7. P. Diagaradjane, A. Shetty, J. C. Wang, A. M. Elliott, J. Schwartz, S. Shentu, H. C. Park, A. Deorukhkar, R. J. Stafford, S. H. Cho, J. W. Tunnell, J. D. Hazle, S. Krishnan, Nano Lett. 2008, 8, 1492.
8. J. Overgaard, S. M. Bentzen, D. Gonzalez, M. C. M. Hulshof, G. Arcangeli, O. Dahl, O. Mella, Lancet 1995, 345, 540.
9. R. A. Vertrees, G. C. Das, V. L. Popov, A. M. Coscio, T. J. Goodwin, R. Logrono, J. B. Zwischenberger, P. J. Boor, Cancer Biol. Ther. 2005, 4, 1144.
10. R. Wilson, Z. Xiaojing, G. Linghong, S. Andrew, H. Xiuying, X. Yeping, G. Sunil, P. Samir, S. Xuejun, C. Jie, M. Ronald, Z. X. James, Nanotechnology 2009, 375101.
11. a) L. Wang, X. Lin, J. Wang, Z. Hu, Y. Ji, S. Hou, Y. Zhao, X. Wu, C. Chen, Adv. Funct. Mater. 2014, 24, 4197;
12. J. Yang, M.-H. Yao, M.-S. Du, R.-M. Jin, D.-H. Zhao, J. Ma, Z.-Y. Ma, Y.-D. Zhao, B. Liu, Chem. Commun. 2015, 51, 2569.
13. R. L. Atkinson, M. Zhang, P. Diagaradjane, S. Peddibhotla, A. Contreras, S. G. Hilsenbeck, W. A. Woodward, S. Krishnan, J. C. Chang, J. M. Rosen, Sci. Transl. Med. 2010, 2, 55ra79.
14. B. Hildebrandt, P. Wust, O. Ahlers, A. Dieing, G. Sreenivasa, T. Kerner, R. Felix, H. Riess, Crit. Rev. Oncol. Hematol. 2002, 43, 33.
15. M. P. Melancon, A. M. Elliott, A. Shetty, Q. Huang, R. J. Stafford, C. Li, J. Controlled Release 2011, 156, 265.
16. M. Loos, J. Kleeff, H. Friess, M. W. Büchler, Ann. N. Y. Acad. Sci. 2008, 1138, 169.
17. a) C.-E. Kim, S. K. Lim, J. S. Kim, J. Controlled Release 2012, 157, 190.
18. b) D. Ciliberto, C. Botta, P. Correale, M. Rossi, M. Caraglia, P. Tassone, P. Tagliaferri, Eur. J. Cancer 2013, 49, 593
19. C. Bornmann, R. Graeser, N. Esser, V. Ziroli, P. Jantscheff, T. Keck, C. Unger, U. Hopt, U. Adam, C. Schaechtele, U. Massing, E. von Dobschuetz, Cancer Chemother. Pharmacol. 2008, 61, 395.
20. D. Kirui, E. Koay, X. Guo, V. Cristini, H. Shen, M. Ferrari, Nanomedicine: NBM 2014, 10, 1487.
21. C. D. Landon, J. Y. Park, D. Needham, M. W. Dewhirst, Open Nanomed. J. 2011, 3, 38.
22. A. Maitra, C. Iacobuzio-Donahue, A. Rahman, T. A. Sohn, P. Argani, R. Meyer, C. J. Yeo, J. L. Cameron, M. Goggins, S. E. Kern, R. Ashfaq, R. H. Hruban, R. E. Wilentz, Am. J. Clin. Pathol. 2002, 118, 52.
23. X. Huang, I. H. El-Sayed, W. Qian, M. A. El-Sayed, J. Am. Chem. Soc. 2006, 128, 2115.
24. R. Choi, J. Yang, J. Choi, E.-K. Lim, E. Kim, J.-S. Suh, Y.-M. Huh, S. Haam, Langmuir 2010, 26, 17520.
25. a) B. Buckway, N. Frazier, A. J. Gormley, A. Ray, H. Ghandehari, Nucl. Med. Biol. 2014, 41, 282.
26. Z. Zhang, J. Wang, X. Nie, T. Wen, Y. Ji, X. Wu, Y. Zhao, C. Chen, J. Am. Chem. Soc. 2014, 136, 7317.
27. J. Yang, M.-H. Yao, M.-S. Du, R.-M. Jin, D.-H. Zhao, J. Ma, Z.-Y. Ma, Y.-D. Zhao, B. Liu, Chem. Commun. 2015, 51, 2569. '
28. G. Kong, R. D. Braun, M. W. Dewhirst, Cancer Res. 2001, 61, 3027.
29. N. Joshi, V. Duhan, N. Lingwal, S. Bhaskar, P. Upadhyay, PLoS One 2012, 7, e32067.
30. D. S. Kapp, G. M. Hahn, R. W. Carlson, Principles of Hyperthermia, Holland-Frei, Ontario 2000.
31. W. Jansen, J. Haveman, Pathol. Res. Pract. 1990, 2, 247.
32. M. G. Calvagno, C. Celia, D. Paolino, D. Cosco, M. Iannone, F. Castelli, P. Doldo, M. Fresta, Curr. Drug Delivery 2007, 4.
33. Y. Barenholz, J. Controlled Release 2012, 160, 117.
34. T. Stylianopoulos, R. K. Jain, Proc. Natl. Acad. Sci. U.S.A. 2013, 110, 18632.
35. Y. Itoh, M. Seiki, J. Cellular Physiol. 2006, 206, 1.
36. S. Dromi, V. Frenkel, A. Luk, B. Traughber, M. Angstadt, M. Bur, J. Poff, J. Xie, S. K. Libutti, K. C. P. Li, B. J. Wood, Clin. Cancer Res. 2008, 13, 2722.
37. R. Weissledder, Nat. Biotechnol. 2001, 19, 316.
38. M. Liu, L. Qi, Y. Zeng, Y. Yang, Y. Bi, X. Shi, H. Zhu, Z. Zhou, J. Sha, PLoS One 2012, 7, e456954.
39. C. Celia, S. Ferrati, S. Bansal, A. van de Ven, B. Ruozi, E. Zabre, S. Hosali, D. Paolino, M. Sarpietro, D. Fine, M. Fresta, M. Ferrari, A. Grattoni, Adv. Healthcare Mater. 2014, 3, 230.
40. D. K. Kirui, J. Mai, A. L. Palange, Q. Guoting, A. L. van de Ven, X. Liu, H. Shen, M. Ferrari, PLoS One 2014, 9, e86489.
41. H. A. Hancock, L. H. Smith, J. Cuesta, A. K. Durrani, M. Angstadt, M. L. Palmeri, E. Kimmel, V. Frenkel, Ultrasound Med. Biol. 2009, 35, 1722.
42. Y. Anna, L. C. Matthieu, D. S. Mariska, L. Sander, G. Holger, M. Chrit, J. Controlled Release 2012, 161, 90.
43. K. N. Sugahara, T. Teesalu, P. P. Karmali, V. R. Kotamraju, L. Agemy, D. R. Greenwald, E. Ruoslahti, Science 2010, 328, 1031.
44. C. Celia, M. G. Calvagno, D. Paolino, S. Bulotta, C. A. Ventura, D. Russo, M. Fresta, J. Nanosci. Nanotechnol. 2008, 8, 2102.
45. a) C. Celia, E. Trapasso, M. Locatelli, M. Navarra, C. A. Ventura, J. Wolfram, M. Carafa, V. M. Morittu, D. Britti, L. Di Marzio, D. Paolino, Colloid Surf. B Biointerface 2013, 112, 548
46. C. Celia, N. Malara, R. Terracciano, D. Cosco, D. Paolino, M. Fresta, R. Savino, Nanomedicine: NBM 2008, 4, 155.
47. M. Celano, M. G. Calvagno, S. Bulotta, D. Paolino, F. Arturi, D. Rotiroti, S. Filetti, M. Fresta, D. Russo, BMC Cancer 2004, 4, 1.
48. S. S. Bansal, C. Celia, S. Ferrati, E. Zabre, M. Ferrari, G. Palapattu, A. Grattoni, Curr. Drug Targets 2013, 14, 1061.
49. M. Licciardi, D. Paolino, C. Celia, G. Giammona, G. Cavallaro, M. Fresta, Biomaterials 2010, 31, 7340.
50. a) P. K. Jain, K. S. Lee, I. H. El-Sayed, M. A. El-Sayed, J. Phys. Chem. B 2006, 110, 7238;
51. M. Hu, J. Chen, Z.-Y. Li, L. Au, G. V. Hartland, X. Li, M. Marquez, Y. Xia, Chem. Soc. Rev. 2006, 35, 1084.
52. A. L. van de Ven, M. Wu, J. Lowengrub, S. R. McDougall, M. A. J. Chaplain, V. Cristini, M. Ferrari, H. B. Frieboes, AIP Adv. 2012, 2, 011208.
53. V. Dudeja, R. K. Chugh, V. Sangwan, S. J. Skube, N. R. Mujumdar, M. B. Antonoff, R. K. Dawra, S. M. Vickers, A. K. Saluja, Am. J. Physiol.- Gastrointestinal Liver Physiol. 2011, 300, G948.